{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:32:23Z","timestamp":1794018743684,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Synchrotron Radiation Laboratory","award":["KY9110000001"],"award-info":[{"award-number":["KY9110000001"]}]},{"name":"The Natural Science Foundation project of Anhui Province","award":["2308085MH237"],"award-info":[{"award-number":["2308085MH237"]}]},{"name":"The Colleges and Universities Provincial Natural Science Research Project of Anhui","award":["2023AH053315"],"award-info":[{"award-number":["2023AH053315"]}]},{"name":"The Research Fund of Anhui Institute of Translational Medicine","award":["2022zhyx-C22"],"award-info":[{"award-number":["2022zhyx-C22"]}]},{"name":"The Coconstruction Project of Clinical and Preliminary Disciplines of Anhui Medical University","award":["2020lcxk003, 2021lcxk005"],"award-info":[{"award-number":["2020lcxk003, 2021lcxk005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients infected with <jats:italic>Acinetobacter baumannii<\/jats:italic> (AB) bacteremia in hospital have high morbidity and mortality. We analyzed the clinical characteristics of pneumonia and nonpneumonia-related AB bloodstream infections (AB BSIs) and explored the possible independent risk factors for the incidence and prognosis of pneumonia-related AB BSIs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective monocentric observational study was performed. All 117 episodes of hospital-acquired AB bacteremia sorted into groups of pneumonia-related AB BSIs (<jats:italic>n<\/jats:italic>\u2009=\u200945) and nonpneumonia-related AB BSIs (<jats:italic>n<\/jats:italic>\u2009=\u200972) were eligible. Univariate\/multivariate logistic regression analysis was used to explore the independent risk factors. The primary outcome was the antibiotic susceptibility in vitro of pneumonia-related AB BSIs group. The secondary outcome was the independent risk factor for the pneumonia-related AB BSIs group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 117 patients with AB BSIs, the pneumonia-related group had a greater risk of multidrug resistant <jats:italic>A. baumannii<\/jats:italic> (MDRAB) infection (84.44%) and carbapenem-resistant <jats:italic>A. baumannii<\/jats:italic> (CRAB) infection (80%). Polymyxin, minocycline and amikacin had relatively high susceptibility rates (&gt;\u200980%) in the nonpneumonia-related group. However, in the pneumonia-related group, only polymyxin had a drug susceptibility rate of over 80%. Univariate analysis showed that survival time (day), CRAB, MDRAB, length of hospital stay prior to culture, length of ICU stay prior to culture, immunocompromised status, antibiotics used prior to culture (n\u2009&gt;\u2009=\u20093 types), endotracheal tube, fiberoptic bronchoscopy, PITT, SOFA and invasive interventions (n\u2009&gt;\u2009=\u20093 types) were associated with pneumonia-related AB bacteremia. The multivariate logistic regression analysis revealed that recent surgery (within 1 mo) [<jats:italic>P<\/jats:italic>\u2009=\u20090.043; 0.306 (0.098\u20130.962)] and invasive interventions (n\u2009&gt;\u2009=\u20093 types) [<jats:italic>P<\/jats:italic>\u2009=\u20090.021; 0.072 (0.008\u20130.671)] were independent risk factors related to pneumonia-related AB bacteremia. Multivariate logistic regression analysis revealed that length of ICU stay prior to culture [<jats:italic>P<\/jats:italic>\u2009=\u20090.009; 0.959 (0.930\u20130.990)] and recent surgery (within 1 mo) [<jats:italic>P<\/jats:italic>\u2009=\u20090.004; 0.260 (0.105\u20130.646)] were independent risk factors for mortality in patients with pneumonia-related AB bacteremia. The Kaplan\u2012Meier curve and the timing test showed that patients with pneumonia-related AB bacteremia had shorter survival time compared to those with nonpneumonia-related AB bacteremia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study found that <jats:italic>A. baumannii<\/jats:italic> had a high rate of antibiotic resistance in vitro in the pneumonia-related bacteremia group, and was only sensitive to polymyxin. Recent surgery was a significantly independent predictor in patients with pneumonia-related AB bacteremia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09335-8","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:01:43Z","timestamp":1714129303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia"],"prefix":"10.1186","volume":"24","author":[{"given":"Meng","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Dongmei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Guodong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Haifeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Guofeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Mengting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xiaoyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"issue":"4","key":"9335_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jhin.2009.03.032","volume":"73","author":"KJ Towner","year":"2009","unstructured":"Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73(4):355\u201363.","journal-title":"J Hosp Infect"},{"issue":"2","key":"9335_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ajic.2021.09.001","volume":"50","author":"Q Ababneh","year":"2022","unstructured":"Ababneh Q, Abulaila S, Jaradat Z. Isolation of extensively drug resistant Acinetobacter baumannii from environmental surfaces inside intensive care units. Am J Infect Control. 2022;50(2):159\u201365.","journal-title":"Am J Infect Control"},{"key":"9335_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12879-016-1526-y","volume":"16","author":"WA Warner","year":"2016","unstructured":"Warner WA, Kuang SN, Hernandez R, Chong MC, Ewing PJ, Fleischer J, Meng J, Chu S, Terashita D, English L, Chen W, Xu HH. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA. BMC Infect Dis. 2016;16:194.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"9335_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jinf.2019.05.017","volume":"79","author":"A Russo","year":"2019","unstructured":"Russo A, Bassetti M, Ceccarelli G, Carannante N, Losito AR, Bartoletti M, Corcione S, Granata G, Santoro A, Giacobbe DR, Peghin M, Vena A, Amadori F, Segala FV, Giannella M, Di Caprio G, Menichetti F, Del Bono V, Mussini C, Petrosillo N, De Rosa FG, Viale P, Tumbarello M, Tascini C, Viscoli C, Venditti M. ISGRI-SITA (Italian Study Group on Resistant Infections of the Societ\u00e0 Italiana Terapia Antinfettiva). Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study. J Infect. 2019;79(2):130\u20138.","journal-title":"J Infect"},{"issue":"10","key":"9335_CR5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1017\/ice.2016.145","volume":"37","author":"RE Nelson","year":"2016","unstructured":"Nelson RE, Schweizer ML, Perencevich EN, Nelson SD, Khader K, Chiang HY, Chorazy ML, Blevins A, Ward MA, Samore MH. Costs and Mortality Associated with Multidrug-Resistant Healthcare-Associated Acinetobacter infections. Infect Control Hosp Epidemiol. 2016;37(10):1212\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"9335_CR6","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jiph.2023.05.024","volume":"16","author":"W Katip","year":"2023","unstructured":"Katip W, Rayanakorn A, Oberdorfer P, Taruangsri P, Nampuan T. Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: a propensity score matching study. J Infect Public Health. 2023;16(8):1249\u201355.","journal-title":"J Infect Public Health"},{"issue":"1","key":"9335_CR7","doi-asserted-by":"publisher","first-page":"11087","DOI":"10.1038\/s41598-022-15397-y","volume":"12","author":"W Jiang","year":"2022","unstructured":"Jiang W, Li L, Wen S, Song Y, Yu L, Tan B. Gram-negative multidrug-resistant organisms were dominant in neurorehabilitation ward patients in a general hospital in southwest China. Sci Rep. 2022;12(1):11087.","journal-title":"Sci Rep"},{"key":"9335_CR8","doi-asserted-by":"crossref","unstructured":"Niu H, Shen X, Liang H, Wu G, Cai S, Shen Q, Zhang K, Chen M, Li J. Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit. Eur J Clin Microbiol Infect Dis. 2023 Sep 28.","DOI":"10.1007\/s10096-023-04668-9"},{"issue":"5","key":"9335_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/ice.2018.58","volume":"39","author":"N Teerawattanapong","year":"2018","unstructured":"Teerawattanapong N, Panich P, Kulpokin D, Na Ranong S, Kongpakwattana K, Saksinanon A, Goh BH, Lee LH, Apisarnthanarak A, Chaiyakunapruk N. A systematic review of the Burden of Multidrug-Resistant Healthcare-Associated infections among Intensive Care Unit patients in Southeast Asia: the rise of Multidrug-Resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2018;39(5):525\u201333.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"9335_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jmii.2014.10.006","volume":"49","author":"CP Liu","year":"2016","unstructured":"Liu CP, Shih SC, Wang NY, Wu AY, Sun FJ, Chow SF, Chen TL, Yan TR. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect. 2016;49(6):934\u201340.","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"9335_CR11","first-page":"1440","volume":"32","author":"Y Huang","year":"2020","unstructured":"Huang Y, Gong C, Fu J, Liu X, Bi H, Wang H, Liu Y, Tang Y, Wang D. [Analysis of prognostic risk factors of bloodstream infection in intensive care unit patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(12):1440\u20134.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"5","key":"9335_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s11739-022-02927-9","volume":"17","author":"M Madrazo","year":"2022","unstructured":"Madrazo M, Piles L, L\u00f3pez-Cruz I, Alberola J, Eiros JM, Zaragoza R, Artero A. Comparison of quick Pitt to quick sofa and sofa scores for scoring of severity for patients with urinary tract infection. Intern Emerg Med. 2022;17(5):1321\u20136.","journal-title":"Intern Emerg Med"},{"key":"9335_CR13","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.2147\/IDR.S419699","volume":"16","author":"F Li","year":"2023","unstructured":"Li F, Zhu J, Hang Y, Chen Y, Gu S, Peng S, Fang Y, Hu L, Xiong J. Clinical characteristics and prognosis of hospital-acquired Klebsiella pneumoniae bacteremic pneumonia versus Escherichia coli Bacteremic Pneumonia: a retrospective comparative study. Infect Drug Resist. 2023;16:4977\u201394.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"9335_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jmii.2014.06.011","volume":"48","author":"SO Teng","year":"2015","unstructured":"Teng SO, Yen MY, Ou TY, Chen FL, Yu FL, Lee WS. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: impact on empiric therapy and antibiotic resistance. J Microbiol Immunol Infect. 2015;48(5):525\u201330.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"9335_CR15","doi-asserted-by":"publisher","first-page":"115229","DOI":"10.1016\/j.diagmicrobio.2020.115229","volume":"99","author":"Y Gu","year":"2021","unstructured":"Gu Y, Jiang Y, Zhang W, Yu Y, He X, Tao J, Hou X, Wang H, Deng M, Zhou M, Xu J. Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case-control study. Diagn Microbiol Infect Dis. 2021;99(2):115229.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9335_CR16","doi-asserted-by":"crossref","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2023 Guidance on the treatment of Antimicrobial resistant gram-negative infections. Clin Infect Dis 2023 Jul 18:ciad428.","DOI":"10.1093\/cid\/ciad428"},{"issue":"24","key":"9335_CR17","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.3346\/jkms.2022.37.e196","volume":"37","author":"D Kim","year":"2022","unstructured":"Kim D, Lee H, Choi JS, Croney CM, Park KS, Park HJ, Cho J, Son S, Kim JY, Choi SH, Huh HJ, Ko KS, Lee NY, Kim YJ. The changes in epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 years. J Korean Med Sci. 2022;37(24):e196.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"9335_CR18","first-page":"124","volume":"20","author":"National Bacterial Drug Resistance Monitoring Network","year":"2021","unstructured":"National Bacterial Drug Resistance Monitoring Network. Changes in Drug Resistance of pathogenic Bacteria in blood samples of the National Bacterial Drug Resistance Monitoring Network [J]. Chin J Infect Control. 2021;20(2):124\u201333.","journal-title":"Chin J Infect Control"},{"issue":"1","key":"9335_CR19","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/cc10036","volume":"15","author":"M Magret","year":"2011","unstructured":"Magret M, Lisboa T, Martin-Loeches I, M\u00e1\u00f1ez R, Nauwynck M, Wrigge H, Cardellino S, D\u00edaz E, Koulenti D, Rello J, EU-VAP\/CAP Study Group. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Crit Care. 2011;15(1):R62.","journal-title":"Crit Care"},{"issue":"5","key":"9335_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jmii.2013.03.004","volume":"46","author":"NY Lee","year":"2013","unstructured":"Lee NY, Lee JC, Li MC, Li CW, Ko WC. Empirical antimicrobial therapy for critically ill patients with Acinetobacter baumannii bacteremia: combination is better. J Microbiol Immunol Infect. 2013;46(5):397\u2013408.","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"9335_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/QCO.0000000000000982","volume":"36","author":"M Bassetti","year":"2023","unstructured":"Bassetti M, Vena A, Giacobbe DR. Management of nonfermenting gram-negative infections: a critique of the guidelines. Curr Opin Infect Dis. 2023;36(6):609\u201314.","journal-title":"Curr Opin Infect Dis"},{"issue":"39","key":"9335_CR22","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.3346\/jkms.2019.34.e256","volume":"34","author":"T Kim","year":"2019","unstructured":"Kim T, Park KH, Yu SN, Park SY, Park SY, Lee YM, Jeon MH, Choo EJ, Kim TH, Lee MS, Lee E. Early intravenous colistin therapy as a favorable prognostic factor for 28-day mortality in patients with CRAB bacteremia: a Multicenter Propensity score-matching analysis. J Korean Med Sci. 2019;34(39):e256.","journal-title":"J Korean Med Sci"},{"key":"9335_CR23","doi-asserted-by":"publisher","first-page":"793615","DOI":"10.3389\/fmed.2022.793615","volume":"9","author":"S Roy","year":"2022","unstructured":"Roy S, Chowdhury G, Mukhopadhyay AK, Dutta S, Basu S. Convergence of biofilm formation and antibiotic resistance in Acinetobacter baumannii infection. Front Med. 2022;9:793615.","journal-title":"Front Med"},{"key":"9335_CR24","doi-asserted-by":"publisher","first-page":"964539","DOI":"10.3389\/fcimb.2022.964539","volume":"12","author":"TT Chiang","year":"2022","unstructured":"Chiang TT, Huang TW, Sun JR, Kuo SC, Cheng A, Liu CP, Liu YM, Yang YS, Chen TL, Lee YT, Wang YC. Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia. Front Cell Infect Microbiol. 2022;12:964539.","journal-title":"Front Cell Infect Microbiol"},{"key":"9335_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/502205","volume":"24","author":"MV Villegas","year":"2003","unstructured":"Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977\u20132000. Infect Control Hosp Epidemiol. 2003;24:284\u201395.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"9335_CR26","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.ajic.2015.11.019","volume":"44","author":"N Guo","year":"2016","unstructured":"Guo N, Xue W, Tang D, Ding J, Zhao B. Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China. Am J Infect Control. 2016;44(4):e37\u20139.","journal-title":"Am J Infect Control"},{"issue":"4","key":"9335_CR27","doi-asserted-by":"publisher","first-page":"e9947","DOI":"10.1371\/journal.pone.0009947","volume":"5","author":"JJ Ye","year":"2010","unstructured":"Ye JJ, Huang CT, Shie SS, et al. Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains. PLoS ONE. 2010;5(4):e9947.","journal-title":"PLoS ONE"},{"issue":"4","key":"9335_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ccc.2020.06.005","volume":"36","author":"C McCarthy","year":"2020","unstructured":"McCarthy C, Fletcher N. Early extubation in enhanced recovery from cardiac surgery. Crit Care Clin. 2020;36(4):663\u201374. https:\/\/doi.org\/10.1016\/j.ccc.2020.06.005. Epub 2020 Aug 13. PMID: 32892820.","journal-title":"Crit Care Clin"},{"issue":"5","key":"9335_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00134-023-07026-7","volume":"49","author":"FG Zampieri","year":"2023","unstructured":"Zampieri FG, Lone NI, Bagshaw SM. Admission to intensive care unit after major surgery. Intensive Care Med. 2023;49(5):575\u20138.","journal-title":"Intensive Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09335-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09335-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09335-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:03:46Z","timestamp":1714129426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09335-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9335"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09335-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (NO: 2023-RE-334). Because of the retrospective and observational nature of the study, the institutional review board waived the requirement for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"448"}}